课题基金 / 基金详情

Novel antibiotic therapies that target bacterial energetic systems

Novel antibiotic therapies that target bacterial energetic systems
针对细菌能量系统的新型抗生素疗法
批准号:
433902
负责人:
Tokuriki Nobuhiko
金额:
$69.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01

项目摘要

项目成果

Tokuriki Nobuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antimicrobial resistance is one of the biggest health, economic and security threats to mankind. Without more effective therapies, it is estimated that 10 million people will die from previously treatable infections by 2050. New therapeutic options are ur
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance (DISTOMOS)
  • 批准号:
    487206
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.42万
  • 财政年份:
    2023
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Comprehensive characterizations for the molecular and evolutionary mechanisms of beta-lactam 'resistome'
  • 批准号:
    443847
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2021
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Evolutionary approaches to treat and evade antibiotic resistant pathogenic bacteria
  • 批准号:
    333587
  • 项目类别:
    Operating Grants
  • 资助金额:
    $77.07万
  • 财政年份:
    2015
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
Metallo-beta-lactamases; mechanistic and evolutionary studies.
  • 批准号:
    268768
  • 项目类别:
    Salary Programs
  • 资助金额:
    $21.86万
  • 财政年份:
    2012
  • 负责人:
    Tokuriki Nobuhiko
  • 依托单位:
海外基金